Subunit vaccines

Subunit vaccines are composed of protein or glycoprotein components of a pathogen that are capable of inducing a protective immune response and may be produced by conventional biochemical or recombinant DNA technologies. Recombinant subunit vaccines have distinct advantages over live attenuated and inactivated vaccines since they are efficient in inducing humoral- and cell-mediated immunological responses, and the risks associated with handling the pathogen are eliminated.

    Related Conference of Subunit vaccines

    August 01-02, 2024

    44th Global Summit and Expo on Vaccines & Immunology

    Montreal, Canada
    September 09-10, 2024

    4th International Conference on Vaccine Research

    Madrid, Spain
    September 09-10, 2024

    7th International Conference on Vaccines and Immunology

    Madrid, Spain
    October 31-01, 2024

    36th International Conference on Vaccines and Immunization

    Amsterdam, Netherlands
    November 28-29, 2024

    6th World Congress on Vaccine and Immunology

    Paris, France

    Subunit vaccines Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in